[{"Assets_0_Q2_USD":"11792200000.0","CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q2_USD":"0.16","CommonStockDividendsPerShareDeclared_2_Q2_USD":"0.32","CommonStockSharesConverted_0_Q2_shares":"142600000.0","CommonStockSharesOutstanding_0_Q2_shares":"142600000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.49","EarningsPerShareBasic_2_Q2_USD":"0.01","EarningsPerShareDiluted_1_Q2_USD":"-0.49","EarningsPerShareDiluted_2_Q2_USD":"0.01","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","MinorityInterest_0_Q2_USD":"0.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"285300000.0","NetIncomeLoss_1_Q2_USD":"-69600000.0","NetIncomeLoss_2_Q2_USD":"2000000.0","OfficialName":"Perrigo Company plc Ordinary Shares","RevenuesConverted_1_Q2_USD":"1237900000.0","RevenuesConverted_2_Q2_USD":"2431900000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":"6081200000.0","StockholdersEquity_0_Q2_USD":"6081200000.0","Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"143300000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"143600000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"143300000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"143300000.0","filed":"20170810","footnote":null,"form":"10-Q","fp":"Q2","fy":"2017.0","name":"PERRIGO CO PLC","period":"20170630","qtrs":"0","uom":"USD"}]